期刊文献+

免疫共沉淀结合微流控芯片技术筛选GBLP相互作用蛋白 被引量:2

Screening of GBLP-interacting Proteins with Co-immunoprecipitation and an Integrated Microfluidic System
下载PDF
导出
摘要 为了进一步阐明G蛋白β亚基2样1蛋白(guanine nucleotide-binding protein subunit beta 2-like 1,GBLP)在普萘洛尔(propranolol,PRO)生物学效应发生机制中的作用,采用免疫共沉淀法结合液相色谱-芯片-离子阱串联质谱(HPLC-CHIP-IT-MS/MS)系统筛选并鉴定人脐静脉内皮细胞(human umbilical vein endothelial cell,HUVEC)中的GBLP相互作用蛋白.结果表明,有7种蛋白与GBLP存在相互作用,分别为酪蛋白α-S1、酪蛋白α-S2、β酪蛋白、桥粒芯蛋白1前体、α-烯醇化酶、果糖二磷酸醛缩酶C、硫氧还原蛋白过氧化物酶2.这些蛋白的生物信息学检索结果提示,GBLP可能参与了细胞的能量代谢调节和抗氧化机制,与普萘洛尔的生物学效应发生机制密切相关. To further elucidate the biological characteristics and the roles of guanine nucleotide-binding protein subunit beta 2-like 1 (GBLP) in response to propranolol (PRO), co-immunoprecipitation and HPLC-CHIP-ITMS/MS were used to screen and identity the GBLP interacting proteins in human umbilical vein endothelial ceils. Seven proteins were shown to interact with GBLP, including casein α-S1, casein α-S2, β casein, desmoglein 1 precursor, α-enolase, fructose-bisphosphate aldolase C and peroxiredoxin 2. These proteins actively involved in energy metabolism of the cell, suggesting that GBLP might participated in the regulation of antioxidation processes, which correlated with the known biological functions of PRO.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2009年第3期276-281,共6页 Chinese Journal of Biochemistry and Molecular Biology
基金 重庆市自然科学基金项目(No.CSTC-2005BB5227)~~
关键词 普萘洛尔 人脐静脉内皮细胞 G蛋白β亚基2样1蛋白(GBLP) 免疫共沉淀 beta 2-like propranolol human umbilical vein endothelial cell guanine nucleotide-binding protein subunit 1 ,GBLP co-immunoprecipitation
  • 相关文献

参考文献12

  • 1毛小琴,邱峰,邱宗荫,陈世知,贾雄飞.普萘洛尔对映异构体诱导HUVEC细胞的蛋白质表达谱差异[J].中国生物化学与分子生物学报,2008,24(2):165-171. 被引量:7
  • 2Chang B Y, Harte R A, Cartwright C A. RACK1 : a novel substrate for the Src protein-tyrosine kinase [ J 1 ~ Oncogene, 2002,21 (50) : 7619- 7629.
  • 3Bolger G B, Baillie G S, Li X, et al. Scanning peptide array analysis identify overlapping binding sites for the signaling scaffold proteins, βarrest in and RACK1, in cAMP- specific phosphodiesterase PDE4D5 [J]. Bioehem J,2006,398(1) :23-36.
  • 4Pass J M, Gao J, Jones W K, et al. Enhanced PKC βⅡ translocation and PKC βⅡ-RACK1 interactions in PKCε-induced heart failure: a role for RACK 1 [ J ]. Am J Physiol Heart Circ Physiol, 2001,281(6 ) : H2500-H2510.
  • 5刘红岩,从玉文,陈波,善亚君,杨振,赵振虎,毛秉智.Mpl相互作用蛋白RACK1的筛选与鉴定[J].军事医学科学院院刊,2005,29(3):204-207. 被引量:2
  • 6Vollmer M, Miller C, Gauthier G L. Comparison of HPLC-Chip/MS with conventional nanoflow LC/MS for proteomic analyses. Agilent tachnologies appliance notes [ M]. Publication Number: 5989- 3538EN. 2005-2008.
  • 7Memar O, Christensen B, Rajaraman S, et al. Induction of blistercausing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3) [J] .J Immunol, 1996,157(7) :3171-3177.
  • 8Asaka M, Kimura T, Nishikawa S, et al. Serum aldolase isozyme levels in patients with cerebrovascular diseases [J]. Am J Med Sei, 1990, 300 (5) : 291-295.
  • 9Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease [ J ]. J Physiol, 2005,563 ( 1 ) : 23-60.
  • 10Mizukami Y, Iwamatsu A, Aki T, et al. ERK1/2 regulates intracellular ATP levels through a-enolase expression in cardiomyocytes exposed to ischemic hypoxla and reoxygenation [J]. J Biol Chem, 2004, 279 (48) : 50120-50131.

二级参考文献25

  • 1张严高,秦永文,吴弘,王文清,文军慧,李闻捷.MAPK在葡萄糖及AngⅡ致血管平滑肌细胞增殖反应中的作用[J].第四军医大学学报,2006,27(22):2026-2028. 被引量:3
  • 2Geddis AE,Linden HM,Kaushansky K.Thrombopoietin:a pan-hematopoietic cytokine[J].Cytokine Growth Factor Rev,2002,13(1):61-73.
  • 3Dorsch M,Danial NN,Rothman PB,et al.A thrombopoietin receptor mutant deficient in Jak-STAT activation mediates proliferation but not differentiation in UT-7 cells[J].Blood,1999,94(8):2676-2685.
  • 4Miyakawa Y,Drachman JG,Gallis B,et al.A structure-function analysis of serine/threonine phosphorylation of the thrombopoietin receptor,c-Mpl[J].J Biol Chem,2000,275(41):32214-32219.
  • 5Meunier C,Bordereaux D,Porteu F,et al.Cloning and characterization of a family of proteins associated with Mpl[J].J Biol Chem,2002,277(11):9139-9147.
  • 6Cox EA,Bennin D,Doan AT,et al.RACK1 regulates integrin-mediated adhesion,protrusion,and chemotactic cell migration via its Src-binding site[J].Mol Biol Cell,2003,14(2):658-669.
  • 7Chang BY,Harte RA,Cartwright CA.RACK1:a novel substrate for the Src protein-tyrosine kinase[J].Oncogene,2002,21(50):7619-7629.
  • 8Geijsen N,Spaargaren M,Raaijmakers JA,et al.Association of RACK1 and PKCbeta with the common beta-chain of the IL-5/IL-3/GM-CSF receptor[J].Oncogene,1999,18(36):5126-5130.
  • 9Guil S,de La Iglesia N,Fernandez-Larrea J,et al.Alternative splicing of the human proto-oncogene c-H-ras renders a new Ras family protein that trafficks to cytoplasm and nucleus[J].Cancer Res,2003,63(17):5178-5187.
  • 10Kim IS,Ryang YS,Kim YS,et al.Leukotactin-1-induced ERK activation is mediated via Gi/Go protein/PLC/PKC delta/Ras cascades in HOS cells[J].Life Sci,2003,73(4):447-459.

共引文献6

同被引文献16

  • 1Stoschitzky K, Egginger G, Zernig G, et al. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies [ J ]. Chirality, 1993,5 ( 1 ) : 15 - 19.
  • 2Oparil S, Zaman M A, Calhoun D A. Pathogenesis of hypertension [J]. Ann Intern Med, 2003, 139(9) : 761 -776.
  • 3Williams B, Lacy P S, Thom S M, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study [J]. Circulation, 2006, 113(9): 1213-1225.
  • 4National Institute for Health and Clinical Excellence (NICE). Clinical guideline 34 [ M ]. Hypertension : management of hypertension in a- dults in primary care. London: 2006: 8.
  • 5Aursnes I, Osnes J B, Tvete I F, et al. Does atenolol differ from other beta-adrenergic blockers? [ J]. BMC Clin Pharmacol, 2007, 7: 4.
  • 6Mohammed S, Kraiczek K, Pinkse M W, et al. Chip-Based Enrich- ment and NanoLC-MS/MS Analysis of Phosphopeptides from Whole Lysates [J]. J Proteome Res, 2008, 7(4) : 1565 -1571.
  • 7Natarajan M, Stewart J E, Golemis E A, et al. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells [ J]. Oncogene, 2006, 25 (12) : 1721 - 1732.
  • 8Dell'Angelica E C. AP-3-dependent trafficking and disease: the first decade[ J]. Curr Opin Cell Biol, 2009, 21 (4): 552- 559.
  • 9Fu Y J, Xiong S, Lovell M A, et al. Quantitative proteomic analysis of mitochondria in aging PS-1 transgenic mice [ J]. Cell Mol Neurobiol, 2009, 29 ( 5 ) : 649 - 664.
  • 10Yego E C, Mohr S. siah-1 Protein is necessary for high glucose-in- duced glyceraldehyde-3-phosphate dehydrogenase nuclear accumula- tion and cell death in Muller cells [J]. J Biol Chem, 2010, 285 (5) : 3181 -3190.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部